Exocan Healthcare Technologies PVT LTD
To demonstrate Proof of Concept for a novel, non-invasive exosome -based screening (for early detection) cum diagnostic kit for multiple cancers (using one test) utilizing patient derived biofluids
ExoCan is the first exosome based oncology company in India developing innovative cancer diagnosis and therapeutics technologies. ExoCan aims to translate the clinical potential of these tiny vesicles for better management of cancers by employing cross-disciplinary approaches at the forefront of exosomes research. We are building up a broad range of biofluids ( e.g. urine, saliva, blood) based oncoplatforms for cancer detection, drug delivery, and R&D purposes.
- ExoCan published in Nanomedicine
- ExoCan featured in biospectrum
- ExoCan Received Dept of Industrial Promotion and Policy (DIPP), Govt of India startup recognition.
- ExoCan is now DIPP, DSIR recognized startup company